EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the ACE/Ang II Axis with Captopril Attenuates Neuroinflammation and Cerebral Injury Following Fat Embolism

Shu Cheng Chen, Chin-Kuo Lin, Cheng-Huang Shen, Michael W Y Chan iD, Zheng-Wei Chen, Yu-Hao Lin, Chung-Sheng Shi iD, Chieh-Mo Lin, Tzu Hsiung Huang, Justin Ching Hsien Lu, Jui-Ming Sun iD, Kwok-Tung Lu und 1 weitere

Cells · 2026

DOI: 10.3390/cells15171550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Shu Cheng Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chia-Yi 621, Taiwan. Hauptthemen laut MEDLINE: Captopril, Embolism, Fat, Peptidyl-Dipeptidase A, Neuroinflammatory Diseases. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiayi Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fat embolism (FE) is a severe complication following long-bone fractures. While the initial mechanical insult primarily affects the pulmonary vasculature, the subsequent systemic hypoxia and inflammatory cascades frequently lead to cerebral fat embolism (CFE). This progression highlights a critical, yet under-explored, pathogenic crosstalk within the lung-brain axis. The Renin–Angiotensin System (RAS), particularly the Angiotensin-Converting Enzyme (ACE)/Angiotensin II (Ang II) pathway, is a potent driver of inflammation and is highly expressed in both pulmonary and cerebral tissues. This study aimed to investigate whether modulating this axis with captopril, a specific ACE inhibitor, could attenuate the lung-brain inflammatory crosstalk and protect against CFE-induced neuroinflammation.

Methods

FE was induced in rats via intravenous injection of fat micelles. Captopril (1, 5, 10, or 20 mg/kg) was administered immediately post-induction. Brain injury was assessed using Oil Red O and H&E staining, brain water content, and malondialdehyde (MDA) assays. ACE expression and localization were evaluated via Western blot and immunofluorescence. The RAS balance was assessed by quantifying Ang II and Ang-(1–7) levels using ELISA. Inflammatory and hypoxic markers, including iNOS, HIF-1α, and phosphorylated ERK (p-ERK), were analyzed by Western blot.

Results

In this study, we observed rapid microvascular occlusion, brain edema, and neuronal damage within 2 h. FE triggered a significant upregulation of ACE, predominantly localized in cortical astrocytes, alongside elevated oxidative stress (MDA) and Ang II levels. Systemic administration of captopril (5 mg/kg) significantly mitigated these cerebral injuries. Captopril not only suppressed local astrocytic ACE expression and Ang II release but also restored the neuroprotective Angiotensin-(1–7) levels. Furthermore, captopril effectively blunted the hypoxia-driven inflammatory cascades, significantly downregulating iNOS expression and the HIF-1α/VEGF/ERK signaling pathway.

Conclusions

Our findings suggest that CFE is a consequence of dysregulated lung-brain axis communication, driven by hypoxia and RAS overactivation. By inhibiting ACE, captopril effectively modulates this axis, reducing oxidative stress and neuroinflammation. Targeting the ACE/Ang II pathway represents a promising therapeutic strategy for managing the neurological complications of FE syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaptoprilEmbolism, FatPeptidyl-Dipeptidase ANeuroinflammatory DiseasesAngiotensin IIBrain InjuriesAnimalsRatsMaleRats, Sprague-DawleyRenin-Angiotensin SystemOxidative StressAngiotensin-Converting Enzyme Inhibitors

Stichwörter der Autor:innen

ACECFERAScaptoprilfat embolismneuroinflammationneuronal damage

Substanzen

CaptoprilPeptidyl-Dipeptidase AAngiotensin IIAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chia-Yi 621, Taiwan.
  • Division of Pulmonary Infection and Critical Care, Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chia-Yi 613, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.
  • Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chia-Yi 600, Taiwan.
  • Department of Biochemical Science and Technology, National Chia-Yi University, Chia-Yi 600, Taiwan.
  • Institute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.

ORCID-Profile: Michael W Y Chan, Chung-Sheng Shi, Jui-Ming Sun

Förderung

  • Chiayi Chang Gung Memorial Hospital

Zitieren

APA

Chen, S. C., Lin, C. K., Shen, C. H., Chan, M. W. Y., Chen, Z. W., Lin, Y. H., Shi, C. S., Lin, C. M., Huang, T. H., Lu, J. C. H., Sun, J. M., Lu, K. T., & Yang, Y. L. (2026). Targeting the ACE/Ang II Axis with Captopril Attenuates Neuroinflammation and Cerebral Injury Following Fat Embolism. Cells. https://doi.org/10.3390/cells15171550

Vancouver

Chen SC, Lin CK, Shen CH, Chan MWY, Chen ZW, Lin YH, et al. Targeting the ACE/Ang II Axis with Captopril Attenuates Neuroinflammation and Cerebral Injury Following Fat Embolism. Cells. 2026. doi:10.3390/cells15171550

BibTeX
@article{Chen2026,
  author = {Chen, Shu Cheng and Lin, Chin-Kuo and Shen, Cheng-Huang and Chan, Michael W Y and Chen, Zheng-Wei and Lin, Yu-Hao and Shi, Chung-Sheng and Lin, Chieh-Mo and Huang, Tzu Hsiung and Lu, Justin Ching Hsien and Sun, Jui-Ming and Lu, Kwok-Tung and Yang, Yi-Ling},
  title = {Targeting the ACE/Ang II Axis with Captopril Attenuates Neuroinflammation and Cerebral Injury Following Fat Embolism},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15171550}
}
Kostenlos starten →